Generic placeholder image

Current Drug Therapy

Editor-in-Chief

ISSN (Print): 1574-8855
ISSN (Online): 2212-3903

Research Article

Effective Topical Psoralen Herbal Hydrogel Expending Capsaicin as a Penetration Enhancer

Author(s): Kamini Bhardwaj*, Pankaj Kumar Sharma, Monika Sachdeva, Pankaj Budhlakoti and Nemai Chandra Ghosh

Volume 18, Issue 1, 2023

Published on: 13 September, 2022

Page: [33 - 48] Pages: 16

DOI: 10.2174/1574885517666220811112147

Price: $65

conference banner
Abstract

Background: This research aims to prepare a hydrogel of psoralen and capsaicin extract for topical application using various gelling agents like Carbopol 940, HPMC, Pluronic 127, and Pectin to minimize the side effect of synthetic drugs in treating psoriasis. Natural, synthetic, and semi-synthetic polymers were utilized for the treatment of psoriasis, and provide a number of benefits, including improved skin permeability, particularly for psoralen, and improved drug stability with improved therapeutic concentration gradients across the skin. Psoriasis is a T cell-mediated autoimmune disease affecting 2-3 % worldwide.

Methods: FTIR and HPLC confirm the extract identification. pH, spreadability, homogeneity, extrudability, phase separation, viscosity, drug content, and stability analysis are all tested on all prepared hydrogels. The releases of psoralen from all prepared formulations are studied in phosphate buffer pH 6.8 using dialysis membranes at 37°C.

Results: The net results conclude that hydrogels made using Carbopol-940 and HPMC (A1, A3, B2, B3) are the most superior and reliable formulations in terms of physicochemical parameters and in vitro permeation studies, out of which 1% carbopol 940 formulations (A3) showed maximum %CDR of 87.96 % much higher compared to other concentration used. Fitting data of the best formulations (A1, A3, B2, B3) obtained from in vitro drug permeation studies showed the release best fitted to the Korsmeyer-Peppas model as indicated by higher R2 value. The optimum formulation (A3) has a higher R2 value, which is then compared with the marketed formulation for the release of psoralen (in vitro), showing that %CDR of the A3 formulation (87.96%) is much higher than the %CDR of the marketed formulation (79.58%), due to the impact of capsaicin which acts as a penetration enhancer and therefore increases psoralen release from the hydrogel.

Conclusion: As a result, the permeability issue with Psoralen for dermal drug administration has been overcome by using capsaicin as a permeability enhancer.

Keywords: Psoralen, hydrogel, capsaicin, carbopol 940, hydroxypropyl methylcellulose, pectin, pluronic 127.

Graphical Abstract

[1]
Traub M, Marshall K. Psoriasis-pathophysiology, conventional, and alternative approaches to treatment. Altern Med Rev 2007; 12(4): 319-30.
[PMID: 18069901]
[2]
Avasatthi V, Pawar H, Dora CP, Bansod P, Gill MS, Suresh S. A novel nanogel formulation of methotrexate for topical treatment of psoriasis: Optimization, in vitro and in vivo evaluation. Pharm Dev Technol 2016; 21(5): 554-62.
[http://dx.doi.org/10.3109/10837450.2015.1026605] [PMID: 26024238]
[3]
Jain A, Doppalapudi S, Domb AJ, Khan W. Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis. J Control Release 2016; 243: 132-45.
[http://dx.doi.org/10.1016/j.jconrel.2016.10.004] [PMID: 27725194]
[4]
Kumar S, Singh KK, Rao R. Enhanced anti-psoriatic efficacy and regulation of oxidative stress of a novel topical babchi oil (Psoralea corylifolia) cyclodextrin-based nanogel in a mouse tail model. J Microencapsul 2019; 36(2): 140-55.
[http://dx.doi.org/10.1080/02652048.2019.1612475] [PMID: 31030587]
[5]
Marwaha TK. Formulation design and evaluation of herbal Anti psoriatic Emulgel. J Pharm Sci Innovation 2013; 2: 30-42.
[http://dx.doi.org/10.7897/2277-4572.02334]
[6]
Patil SC, Gadade DD, Rathi PB. Design, development and evaluation of herbal gel for treatment of psoriasis. J Innov Pharm Biol Sci 2015; 2(1): 72-87.
[7]
Ramanunny AK, Wadhwa S, Singh SK, Sharma DS, Khursheed R, Awasthi A. Treatment strategies against psoriasis: Principle, perspectives and practices. Curr Drug Deliv 2020; 17(1): 52-73.
[http://dx.doi.org/10.2174/1567201816666191120120551] [PMID: 31752655]
[8]
Aiyalu R, Govindarajan A, Ramasamy A. Formulation and evaluation of topical herbal gel for the treatment of arthritis in the animal model. Braz J Pharm Sci 2016; 52(3): 493-507.
[http://dx.doi.org/10.1590/s1984-82502016000300015]
[9]
Xie J, Huang S, Huang H, et al. Advances in the application of natural products and the novel drug delivery systems for psoriasis. Front Pharmacol 2021; 12: 644952.
[http://dx.doi.org/10.3389/fphar.2021.644952] [PMID: 33967781]
[10]
Singh Malik D, Mital N, Kaur G. Topical drug delivery systems: A patent review. Expert Opin Ther Pat 2016; 26(2): 213-28.
[http://dx.doi.org/10.1517/13543776.2016.1131267] [PMID: 26651499]
[11]
Verma AS, Singh SU, Kaur R, Jain UK. Formulation and evaluation of clobetasol propionate gel. Asian J Pharm Clin Res 2013; 6(5): 15-8.
[12]
Davoodi-Roodbordeii F, Afshar M, Tabrizi FH, et al. Topical hydrogel containing Fumaria vaillantii Loisel. Extract enhances wound healing in rats. BMC Complement Altern Med 2019; 19(1): 1-9.
[http://dx.doi.org/10.1186/s12906-019-2645-y] [PMID: 30606178]
[13]
Ved CH, Shrotriya SN. Formulation and evaluation of fluticasone propionate hydrogel for topical drug delivery. Inventi Journals 2014; (4): 1-5.
[14]
Gul R, Jan SU, Ahmad M, Mukhtiar M. Formulation of Hedera helix L. in topical dosage forms: In vitro and ex vivo evaluation. Dissolut Technol 2018; 25(2): 40-7.
[http://dx.doi.org/10.14227/DT250218P40]
[15]
Bakshi H, Nagpal M, Singh M, Dhingra GA, Aggarwal G. Treatment of psoriasis: A comprehensive review of entire therapies. Curr Drug Saf 2020; 15(2): 82-104.
[http://dx.doi.org/10.2174/1574886315666200128095958] [PMID: 31994468]
[16]
Ganesh TA, Manohar SD, Bhanudas SR. Hydrogel- a novel technique for preparation of topical gel. World J Pharm Pharm Sci 2013; 2(6): 4520-41.
[17]
Yadav K, Soni A, Singh D, Singh MR. Polymers in topical delivery of anti-psoriatic medications and other topical agents in overcoming the barriers of conventional treatment strategies. Prog Biomater 2021; 10(1): 1-17.
[http://dx.doi.org/10.1007/s40204-021-00154-7] [PMID: 33738750]
[18]
Gulrez SK, Al-Assaf S, Phillips GO. Hydrogels: Methods of preparation, characterisation and applications. In: Carpi A, Ed. Progress in Molecular and Environmental Bioengineering-from Analysis and Modeling to Technology Applications. London, UK: IntechOpen 2011; pp. 117-50.
[http://dx.doi.org/10.5772/24553]
[19]
Bahram M, Mohseni N, Moghtader M. An introduction to hydrogels and some recent applications. In: Majee SB, Ed. Emerging Concepts in Analysis and Applications of Hydrogels. London, UK: IntechOpen 2016.
[http://dx.doi.org/10.5772/64301]
[20]
Chen M, Alexander K, Baki G. Formulation and evaluation of antibacterial creams and gels containing metal ions for topical application. J Pharm 2016; 2016: 5754349.
[21]
Sri B, Ashok V, Arkendu C. As a review on hydrogels as drug delivery in the pharmaceutical field. Int J Pharm Chem Sci 2012; 1(2): 642-1.
[22]
Prashant S. Malpure. A review on- hydrogel. Am J PharmTech Res 2018; 8(3): 43-61.
[23]
Mishra B, Upadhyay M, Reddy Adena SK, Vasant BG, Muthu MS. Hydrogels: An introduction to a controlled drug delivery device, synthesis and application in drug delivery and tissue engineering. Austin J Biomed Eng 2017; 4(1): 1037-49.
[24]
Barbosa AI, Torres T, Lima SA, Reis S. Hydrogels: A promising vehicle for the topical management of atopic dermatitis. Adv Ther (Weinh) 2021; 4(7): 2100028.
[http://dx.doi.org/10.1002/adtp.202100028]
[25]
Tomar S, Singhal T. Preformulation studies of niosomal gel of prednisolone & Azithromycin for topical drug delivery system. JIPBS 2015; 2(3): 312-21.
[26]
Gibson M. Pharmaceutical preformulation and formulation: A practical guide from candidate selection to commercial dosage form. CRC Press: Boca Raton, USA, 2009.
[27]
Laxmi RJ, Karthikeyan R, Babu PS, Babu RN. Formulation and evaluation of antipsoriatic gel using natural excipients. J Acute Dis 2013; 2(2): 115-21.
[http://dx.doi.org/10.1016/S2221-6189(13)60110-9]
[28]
Lachman L, Lieberman HA, Kanig JL. Theory and practice of industrial pharmacy. (4th Indian Edition.), Mumbai: Verghese Publishing House 1991.
[29]
Raut S, Suruse PB, Shivhare UD, Bhusari KP. Development and evaluation of non-ionic surfactant based organogels for transdermal delivery of zidovudine. Int J Comprehen Pharm 2010; 3(7): 1-7.
[30]
Shin SC, Cho CW, Choi HK. Permeation of piroxicam from the poloxamer gels. Drug Dev Ind Pharm 1999; 25(3): 273-8.
[http://dx.doi.org/10.1081/DDC-100102171] [PMID: 10071819]
[31]
Kumari K, Sara UV, Sachdeva M. Formulation and evaluation of topical hydrogel of mometasone furoate using different polymers. Int J Pharm Chem Sci 2013; 2: 89-100.
[32]
Ubaid M, Ilyas S, Mir S, et al. Formulation and in vitro evaluation of carbopol 934-based modified clotrimazole gel for topical application. An Acad Bras Cienc 2016; 88(4): 2303-17.
[http://dx.doi.org/10.1590/0001-3765201620160162] [PMID: 27925034]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy